Lösemi kemik iliğin ve lökositlerin kanseridir
Löseminin 4 türü var: Akut miyelojenöz (AML), Akut lenfoblastik (ALL), Kronik miyelojen (CML) ve Kronik lenfositik (CLL)
Akut lenfoplastik en çok çocukların yakaladığı lösemi türüdür
Her sene 10 000’den fazla kadın, erkek ve çocuk, kemik iliği naklinden faydalanabilir
Her sene 10 000’den fazla insan, lösemi ya da lenfoma gibi kan hastalıklarla teşhis oluyor
Lösemi, 15 yaşından küçük, kansere yakalanan çocukların 1/3 ‘nin ölümüne neden oluyor
Lösemi en çok genç yaşltakilerin kanser türü olduğu halde, her 10 vakadan 9’u yetişkinlerde teşhis oluyor
Lösemi, bütün uyruk ve ırklarda en çok rastlanan kanser türüdür
Kemik iliği transplantasyonu, lösemi, lenfoma ve başka kan kanserlere yakalanan insanların hayatını kurtarabiliyor
Kemik iliği transplantasyona ihtiyacı olan hastaların %70’i kendi ailesinden uyumlu donör bulamıyor
Kemik iliği transplantasyona ihtiyacı olan hastaların sadece %30’u kendi ailesinden uyumlu donör bulabiliyor
Her 10 hastalarından sadece 3 hayatını kurtaracak nakli alıyor
En çok lazım olan donörlerin yaşları 18-24 yaş arasındadır
Löseminin türleri en çok erkeklerde teşhis oluyor.
The Karaiskakio Foundation has received funding under the Norwegian Financial Mechanism in the Programming Period 2009-2014, for upgrading part of its infrastructure, advancement of expertise on the subject, promotion of public awareness and enhancement the bone marrow donor registry in Cyprus. Aiming to improve public health and reduce health inequalities, through the proposed project, the Karaiskakio Foundation has enhanced its local health infrastructure with the establishment of a state-of-the art, specialised Childhood Cancer Diagnostic Laboratory which provides diagnostic support to the paediatric and other cancer patients.
The establishment of the Childhood Cancer Diagnostic Laboratory contributes towards:
• Technological progress in the diagnostic field and better understanding of cancer pathology, improvement of patient health and reduction of health inequalities
• Integrated and comprehensive analysis at the early stage of disease identification and classification, management, and treatment
• Structured, systematic and comprehensive laboratory support to patients, hence minimizing the time needed for diagnosis
• Opportunities to young scientists to excel in the field of cancer, invest in people through education
• Increase Social Awareness on cancer.
A parallel objective of the project is the enhancement of the Bone Marrow Donor Registry with new volunteer donors. The challenge is to find the means to attract and to cultivate the feeling of altruism in young adults, through modern means of communication (e.g., apps, social media, self-service stations, short videos etc).
The project further enhances the collaboration of the Greek Cypriot and the Turkish Cypriot Communities in Cyprus.
The Karaiskakio Foundation is already engaged in bi-communal collaboration through the Cyprus Bone Marrow Donor Registry, the greatest in significance and size bi-communal project since 1974. The Kemal Saracoglu Association (a Turkish Cypriot NGO) actively supports the Karaiskakio Foundation in contacting donors and serves as a contact point to help Turkish Cypriot patients and physicians to access the services of the Foundation. Furthermore, the Karaiskakio Foundation is providing both diagnostic and donor search services free of charge to all leukaemia and cancer patients from both the Greek and the Turkish Cypriot community.